More Press Releases

View Older Stories View Newer Stories

Nov 15, 2024 02:30AM Karolinska Development's portfolio company SVF Vaccines appoints Dr Gaston Picchio as acting CEO
Nov 15, 2024 02:30AM Terranet signs an agreement with a global leader in the automotive industry
Nov 15, 2024 02:26AM The Centennial Celebration of Sun Yat-sen University Held in Guangzhou
Nov 15, 2024 02:22AM Noster Inc research: Celebrating Breakthroughs in Gut Microbiome
Nov 15, 2024 02:15AM Bekaert - Update on the Liquidity Agreement
Nov 15, 2024 02:00AM Centamin PLC Announces Notification of Major Holdings
Nov 15, 2024 02:00AM District Provides Update on the Uranium Moratorium in Sweden
Nov 15, 2024 02:00AM Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR
Nov 15, 2024 02:00AM WithSecure launches a new Employee Share Savings Plan period for 2025-2027
Nov 15, 2024 02:00AM PARROT: 2024 3rd quarter business
Nov 15, 2024 02:00AM Suspension of Listing
Nov 15, 2024 02:00AM Interim Report - January-September 2024
Nov 15, 2024 02:00AM InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 15
Nov 15, 2024 02:00AM Transaction in Own Shares
Nov 15, 2024 02:00AM Enefit Green production data – October 2024
Nov 15, 2024 02:00AM Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR
Nov 15, 2024 02:00AM Claranova Will Be Present at the “Investir Day” Event on November 26 at the Carrousel du Louvre in Paris
Nov 15, 2024 02:00AM Meeting of the Board of Directors of Valerio Therapeutics S.A. on November 13, 2024
Nov 15, 2024 02:00AM TotalEnergies, bp, Equinor and Shell Join Forces to Help Increase Access to Energy
Nov 15, 2024 02:00AM Amaroq Minerals Announces Key Agreements in Preparation for Gold Production in Nalunaq
Nov 15, 2024 02:00AM Closed Period Notification
Nov 15, 2024 01:45AM BW Offshore: Dividend information
Nov 15, 2024 01:38AM Bavarian Nordic Announces Interim Results for the First Nine Months of 2024
Nov 15, 2024 01:37AM CASETiFY Expands Into Travel
Nov 15, 2024 01:35AM Preliminary October results of Novaturas: 5% increase in revenue, continued growth in load factor
Nov 15, 2024 01:30AM BW Offshore: Third quarter results 2024
Nov 15, 2024 01:30AM Vallourec Third Quarter 2024 Results
Nov 15, 2024 01:30AM Sampo plc’s share buybacks 14 November 2024
Nov 15, 2024 01:30AM Bw Energy: Third Quarter Results 2024
Nov 15, 2024 01:24AM Kodiak Gas Services Announces Pricing of Upsized Offering of Common Stock by Selling Stockholder
Nov 15, 2024 01:15AM Yichang, a harmonious blend of nature and urban life, launched video series "Wilderness Explorations"
Nov 15, 2024 01:20AM
Nov 15, 2024 01:13AM CLAWCLOUD Launches its High-Performance, Low-Cost Virtual Private Server Solution
Nov 15, 2024 01:09AM NINER Pharmaceutical Strengthens Global Presence with Strategic IV Fluid Supply Initiative for the U.S. and Latin American Markets
Nov 15, 2024 01:15AM Yichang, a harmonious blend of nature and urban life, launched video series "Wilderness Explorations"
Nov 15, 2024 01:00AM KaJ Labs Launches Colle AI NFT Mobile App on Google Play Store
Nov 15, 2024 01:00AM KaJ Labs Launches Colle AI NFT Mobile App on Google Play Store
Nov 15, 2024 01:00AM KaJ Labs Announces AI & Web3 Festival - Chain Fest
Nov 15, 2024 01:00AM KaJ Labs Announces AI & Web3 Festival - Chain Fest
Nov 15, 2024 01:00AM KaJ Labs Announces AI & Web3 Festival - Chain Fest
Nov 15, 2024 01:00AM KaJ Labs Announces AI & Web3 Festival - Chain Fest
Nov 15, 2024 01:00AM KaJ Labs Announces AI & Web3 Festival - Chain Fest
Nov 15, 2024 01:00AM KaJ Labs Announces AI & Web3 Festival - Chain Fest
Nov 15, 2024 01:00AM 1win and David Warner Launch Charitable #1win1000hits Challenge
Nov 15, 2024 01:00AM Start of Day Message
Nov 15, 2024 01:00AM Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
Nov 15, 2024 01:00AM Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio
Nov 15, 2024 01:00AM Aegon trading update for third quarter 2024
Nov 15, 2024 01:00AM Richemont's 2024 Interim Report now available online
Nov 15, 2024 12:59AM Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
View Newer Stories View Older Stories